Tyson 2.0
Series A in 2022
Tyson 2.0 is a cannabis company founded by renowned boxer and entrepreneur Mike Tyson, focused on producing high-quality cannabis products. The company offers a diverse range of offerings, including full-spectrum cannabis flower, concentrates, and consumables, which are designed to ensure both purity and precision. Tyson 2.0 aims to provide consumers with an exceptional selection that balances premium quality and affordability, making its products widely accessible at retailers across the nation.
Allumia LLC, established in 2013 and headquartered in Seattle, Washington, specializes in lighting upgrade services for commercial markets. The company evaluates existing lighting systems, proposes energy-efficient designs, installs upgraded hardware, and provides ongoing maintenance. Allumia serves diverse sectors including commercial, athletic, automotive, and industrial clients nationwide through its offices in Seattle, Los Angeles, and Durham. Its unique Energy Efficiency-as-a-Service model optimizes project financing, development, metering, and maintenance via a proprietary software and IoT platform, enabling clients to achieve significant cost savings and improved energy efficiency.
Pistil Data
Seed Round in 2021
Pistil Data is a prominent market intelligence company specializing in the cannabis sector, focusing on consumer packaged goods (CPG) brands and retailers. The company has developed a comprehensive cannabis market intelligence platform that delivers tailored sales opportunities and insights. This platform provides detailed information on various brands and products within the cannabis category, allowing users to identify retailers and monitor significant market changes. By helping cannabis brands optimize their shelf space and expand their market presence, Pistil Data empowers businesses to leverage data effectively and enhance their sales potential.
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
Cityrow Go
Series A in 2021
CityRow Holdings, Inc. specializes in health and fitness services, offering a unique blend of workouts that include yoga, strength training, and cardio, primarily utilizing water-based rowing machines. Founded in 2014 and headquartered in New York City, the company operates three locations in Michigan and New York. CityRow also provides a digital platform, Cityrow Go, which is a rowing-based fitness app designed for smartphones and tablets. This app features a variety of rowing classes aimed at delivering effective and motivating workouts for users at home. The studio's approach focuses on enhancing aerobic capacity and overall body efficiency through high-intensity interval training that emphasizes low-impact exercises, helping individuals achieve their fitness goals in a scientifically guided manner.
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
Gage Cannabis
Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
High 12 is a consumer packaged goods company based in Toronto, Canada, specializing in the development and operation of premier global cannabis brands. Founded in 2018, the company emphasizes a consumer-focused approach, utilizing data-driven analysis to create and launch recognizable cannabis products. High 12 aims to build strong brands that foster community and connection among users, while also forming strategic supply-chain partnerships to enhance its market presence. Through its commitment to brand development, High 12 seeks to establish a significant footprint in the evolving cannabis industry.
Canndescent
Series C in 2019
Canndescent LLC is a cannabis company based in Santa Barbara, California, specializing in the cultivation of premium cannabis flowers for medical purposes. The company employs a proprietary cultivation technology that enhances aromas and flavors, ensuring a consistent product for its customers. Canndescent distinguishes itself by abandoning traditional strain names, allowing for a more straightforward understanding of its offerings. Committed to compliance with state and local regulations, the company manages the entire process from cultivation to packaging and distribution, providing a quality-driven service that emphasizes deep cultivation expertise.
Semasio
Seed Round in 2019
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
Henry's Original
Series B in 2019
Henry's Original is a producer of handcrafted cannabis products sourced from family-run farms in Mendocino County. Established in mid-2017, the company focuses on delivering health and wellness-oriented cannabis offerings, including flower, pre-rolls, singles, and flower vape cartridges in seasonal varieties and CBD-heavy options. All products are cultivated in Mendocino County, ensuring they meet and exceed California State standards for organic quality. Henry's Original has garnered attention from various media outlets, reflecting its commitment to providing consumers with access to organically grown cannabis directly from the farm.
GrowGeneration
Post in 2019
GrowGeneration is a private company that specializes in the operation of hydroponic and organic gardening retail stores. The company focuses on capitalizing on the growing demand for home gardening and the legalization of marijuana. It serves as a marketer and distributor of a wide range of products essential for hydroponic gardening, including nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and various accessories. GrowGeneration operates through two main segments: the Cultivation and Gardening segment, which encompasses its hydroponic and organic gardening business, and the Storage Solutions segment, which includes its offerings in benching, racking, and storage solutions.
Vitruvias Therapeutics
Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company based in Montgomery, Alabama, founded in 2013. The company specializes in the development of niche topical generic products that are available only by prescription. It focuses on creating complex active pharmaceutical ingredients (APIs) and finished dosage forms that are challenging to manufacture. By leveraging strategic partnerships, Vitruvias aims to address manufacturing complexities and raw material sourcing issues, thereby enhancing the availability of essential generic medications. The company's name is inspired by Leonardo da Vinci's "Vitruvian Man," symbolizing its commitment to achieving the ideal balance and proportionality in pharmaceutical development.
TerrAscend Corp. is a Canadian cannabis company that cultivates, processes, and sells medical and adult-use cannabis in Canada, the United States, and Europe. Founded in 2017 and headquartered in Mississauga, the company operates through subsidiaries that provide physician consultations, patient education, and support programs. It focuses on developing quality products that address the needs of patients, including prescription cannabinoids and medical cannabis solutions for those suffering from chronic pain and debilitating illnesses. Additionally, TerrAscend manufactures cannabis-infused artisan edibles and distributes hemp-derived wellness products to retail locations, while also operating retail dispensaries in California and Pennsylvania. The company is dedicated to drug research and development, as well as the advancement of cannabis delivery systems and health products.
Vensun Pharmaceuticals
Series C in 2016
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.
Establishment Labs
Debt Financing in 2016
Establishment Labs, founded in 2004, is a medical technology company based in Alajuela, Costa Rica. It specializes in designing, manufacturing, and marketing silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a wide range of breast implants with various surface, shape, size, base, and projection choices. Additionally, Establishment Labs provides Q Inside Safety Technology, a radio frequency identification transponder for implant data access, and Divina 3D imaging technology for surgical planning. Its products are sold through exclusive distributors and direct sales to plastic surgeons, hospitals, and clinics in over 80 countries worldwide. The company's manufacturing facilities adhere to strict FDA and ISO standards.
Establishment Labs
Venture Round in 2015
Establishment Labs, founded in 2004, is a medical technology company based in Alajuela, Costa Rica. It specializes in designing, manufacturing, and marketing silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a wide range of breast implants with various surface, shape, size, base, and projection choices. Additionally, Establishment Labs provides Q Inside Safety Technology, a radio frequency identification transponder for implant data access, and Divina 3D imaging technology for surgical planning. Its products are sold through exclusive distributors and direct sales to plastic surgeons, hospitals, and clinics in over 80 countries worldwide. The company's manufacturing facilities adhere to strict FDA and ISO standards.
Aralez Pharmaceuticals
Post in 2015
Aralez Pharmaceuticals is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of products primarily in cardiovascular care, pain management, and other specialized areas. The company offers a range of key products such as Fiorinal, Proferrin, Fibricor, Uracyst, Neovisc, and Cambia. Aralez operates primarily in the United States and Canada, with the majority of its revenue generated from the U.S. market. By serving customers worldwide, Aralez Pharmaceuticals aims to address significant medical needs through its targeted therapeutic offerings.
Vensun Pharmaceuticals
Series B in 2013
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.
Vensun Pharmaceuticals
Series A in 2012
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.
Arbor Pharmaceuticals
Series B in 2010
Arbor Pharmaceuticals is a specialty pharmaceutical company based in Raleigh, North Carolina, founded in 2006. It primarily focuses on pediatric medicine, licensing, developing, and commercializing late-stage products designed for common pediatric conditions. The company offers a range of products, including ZINOTIC and ZINOTIC ES for treating Acute Otitis Externa, NEOTIC for pain and inflammation associated with Acute Otitis Media, and XYLAREX for dietary management of Recurrent Acute Otitis Media. Additionally, Arbor Pharmaceuticals provides the Pediaderm HC Complete Kit, specifically formulated to treat and protect the skin of children with atopic dermatitis, commonly known as eczema. The company markets its products through specialized sales forces across the United States, while also engaging in research and development in therapeutic areas like cardiology, neurology, and endocrinology.